SOPHiA GENETICS

SOPHiA GENETICS is the creator of a global data-sharing network – we work with customers from over 780+ institutions in over 70 countries.  Our network advances data-driven medicine to improve health outcomes and economics worldwide.

We offer a cloud-based Software-as-a-Service platform — the SOPHiA DDM™ platform — that enables healthcare institutions to get quick, robust insights from their data. We apply our technology to diseases such as cancer and inherited disorders, where combining genomic and phenotypic information is vital to support discoveries, treatment decisions, and drug development efforts.

The company's achievements and innovative approach is recognized by the MIT Technology Review "50 Smartest Companies".